Related Experiment Video
Updated: Jun 14, 2026
12:03
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Arginine as a synergistic virucidal agent
Satoshi Ohtake1, Tsutomu Arakawa, A Hajime Koyama
1Aridis Pharmaceuticals, 5941 Optical Court, San Jose, CA 95138, USA.
Molecules (Basel, Switzerland)
|March 26, 2010
Summary
Arginine enhances virus inactivation when combined with acidic pH and high temperatures. This synergy may reduce treatment toxicity, offering a safer approach to developing antiviral agents and disinfectants.
Area of Science:
- Virology
- Biochemistry
- Materials Science
Background:
- Infectious disease spread necessitates effective, environmentally friendly disinfectants (virucidal agents).
- Current virucidal treatments often exhibit toxicity, limiting their therapeutic applications.
- Arginine has demonstrated synergistic effects with existing virucidal conditions.
Purpose of the Study:
- To investigate the mechanism of arginine-mediated virus inactivation.
- To explore how arginine reduces the toxicity of virucidal agents.
- To correlate virus structural damage with infectivity and inactivation.
Main Methods:
- Analysis of virus structural damage induced by physical and chemical stresses.
- Examination of virus inactivation and aggregation under various stress conditions.
- Application of knowledge regarding aqueous arginine solution properties.
Main Results:
- Arginine potentiates virus inactivation under acidic pH and high-temperature conditions.
- The synergistic effect of arginine may mitigate the toxic side effects of conventional virucidal treatments.
- Understanding stress-induced viral damage is key to elucidating arginine's mechanism.
Conclusions:
- Arginine shows promise as a component in safer, more effective antiviral strategies.
- Further research into arginine's mechanism can guide the development of novel disinfectants and chemotherapeutics.
- Correlating structural damage with infectivity is crucial for understanding virus inactivation processes.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...